Vir Biotechnology
VIR
VIR
205 hedge funds and large institutions have $908M invested in Vir Biotechnology in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 72 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
205
Holders Change
-8
Holders Change %
-3.76%
% of All Funds
3.01%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
69
Reduced
72
Closed
33
Calls
$3.64M
Puts
$2.3M
Net Calls
+$1.35M
Net Calls Change
+$1.08M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$30.6M |
| 2 |
2
Morgan Stanley
New York
|
$42.8M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$124M |
| 4 |
4
BlackRock
New York
|
$170M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$5.29M |
